Cargando…

Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial

PURPOSE: In sub-Saharan Africa, Kaposi sarcoma (KS) is the most common HIV-associated cancer. KS causes substantial morbidity, and treatment goals should emphasize quality of life (QOL). Antiretroviral therapy (ART) is indicated, and early chemotherapy significantly improves tumor regression. The ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaik, Fahmida, Uldrick, Thomas S., Esterhuizen, Tonya, Mosam, Anisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2018
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818281/ https://www.ncbi.nlm.nih.gov/pubmed/30354935 http://dx.doi.org/10.1200/JGO.18.00105

Ejemplares similares

HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
por: Mosam, Anisa, et al.
Publicado: (2010)

Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
por: Uldrick, TS, et al.
Publicado: (2009)

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
por: Mosam, A, et al.
Publicado: (2010)

Brain localization of Kaposi’s sarcoma in a patient treated by combination antiretroviral therapy
por: Baldini, Francesco, et al.
Publicado: (2013)

Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
por: Uldrick, TS, et al.
Publicado: (2009)

Rapidly Disseminated Kaposi’s Sarcoma Despite Initiation of Antiretroviral Therapy
por: Saberian, Chantal, et al.
Publicado: (2023)

Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America
por: Castilho, Jessica L, et al.
Publicado: (2021)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
por: Nguyen, HQ, et al.
Publicado: (2009)

Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi
por: Herce, Michael E, et al.
Publicado: (2015)

Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome
por: Ngalamika, Owen, et al.
Publicado: (2021)

The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi’s Sarcoma Tumors during Antiretroviral Therapy
por: Nolan, David J., et al.
Publicado: (2022)

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
por: Franceschi, S, et al.
Publicado: (2008)

Multicentric Castleman’s Disease and Kaposi’s Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy
por: Ortega, Lauro, et al.
Publicado: (2014)

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
por: Franceschi, S, et al.
Publicado: (2009)

Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma
por: Tedeschi, Rosamaria, et al.
Publicado: (2015)

Pulmonary Kaposi Sarcoma: an uncommon presentation in HIV heterosexual female on antiretroviral therpay
por: Bhattarai, Bikash, et al.
Publicado: (2020)

A Case of Ocular Kaposi’s Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel
por: Jin, Chongfei, et al.
Publicado: (2018)

Impact of Kaposi Sarcoma on Quality of Life Amongst HIV-infected Adults Initiating Antiretroviral Therapy in East Africa
por: Scott, Lu, et al.
Publicado: (2023)

Impact of Antiretroviral Therapy on the Risk of Recurrence in HIV-1 Infected Patients with Kaposi Sarcoma: A Multicenter Cohort Experience
por: Colafigli, Manuela, et al.
Publicado: (2019)

Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya
por: Busakhala, Naftali, et al.
Publicado: (2019)

Restricted Kaposi’s Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy
por: Dittmer, Dirk P.
Publicado: (2011)

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study
por: Akanbi, Maxwell. O., et al.
Publicado: (2023)

Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt’s lymphoma and Kaposi’s sarcoma
por: Kim, Seong Eun, et al.
Publicado: (2018)

Pulmonary Kaposi Sarcoma with Osseous Metastases in an Human Immunodeficiency Virus (HIV) Patient: A Remarkable Response to Highly Active Antiretroviral Therapy
por: Dirweesh, Ahmed, et al.
Publicado: (2017)

Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study
por: Maskew, Mhairi, et al.
Publicado: (2013)

T cell immunosenescence is associated with the presence of Kaposi’s sarcoma in antiretroviral treated human immunodeficiency virus-infected persons
por: Unemori, Patrick, et al.
Publicado: (2010)

AIDS-related Kaposi’s sarcoma: outcomes after initiation of highly active antiretroviral therapy under routine conditions in Zimbabwe
por: Nelson, Bradley, et al.
Publicado: (2010)

The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men
por: Luu, H N, et al.
Publicado: (2013)

Pulmonary Kaposi Sarcoma: An Uncommon Cause of Respiratory Failure in the Era of Highly Active Antiretroviral Therapy—Case Report and Review of the Literature
por: Nwabudike, Stanley M., et al.
Publicado: (2016)

1596 Spectrum of Kaposi's sarcoma encountered among HIV-infected patients in an inner-city hospital in the established antiretroviral era
por: Nguyen, Minh Ly, et al.
Publicado: (2014)

HIV persistence in tissue macrophages of humanized myeloid only mice during antiretroviral therapy
por: Honeycutt, J. B., et al.
Publicado: (2017)

Pulmonary Kaposi Sarcoma as an Unusual Etiology of Acute Hypoxemic Respiratory Failure in the Era of Highly Active Antiretroviral Therapy: A Case Report
por: Mohamed, Abdelnasir, et al.
Publicado: (2022)

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi’s Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya
por: Busakhala, Naftali W., et al.
Publicado: (2018)

Progressive HIV-associated Cholangiopathy in an HIV Patient Treated with Combination Antiretroviral Therapy
por: Imai, Kazuo, et al.
Publicado: (2016)

Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy
por: Mandas, Antonella, et al.
Publicado: (2009)

Relationship between salivary shedding and seropositivity for Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) among South African children and adults: insights on why EBV infection is ubiquitous and KSHV is not
por: Butler, Lisa, et al.
Publicado: (2010)

Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy
por: Mwafongo, Albert A., et al.
Publicado: (2014)

Classic Kaposi Sarcoma: to treat or not to treat?
por: Vincenzi, Bruno, et al.
Publicado: (2015)

Pregnant Women's Access to PMTCT and ART Services in South Africa and Implications for Universal Antiretroviral Treatment
por: Hussain, Akthar, et al.
Publicado: (2011)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_utvaadq5vo5p8sacsrioan191a